Effectiveness and safety of first-line atezolizumab in locally advanced or metastatic urothelial cancer: The IMFLAME study.

被引：0
|
作者：
Lista, Alfonso Gomez De Liano
Romero-Laorden, Nuria
Gajate, Pablo
Orta-Ruiz, Alberto
Jimenez, Jesus Garcia-Donas
Miranda, Maria Jose
Estevez, Sergio Vazquez
Molins, Carmen
Pernaut, Cristina
Cordero, Marta Gonzalez
Fernandez, Ovidio
Sanchez, Jose Garcia
Maeso, Iria Gonzalez
Blazquez, Patricia Rodriguez
Reig, Oscar
Maroto-Rey, Pablo
Martin, Almudena
Ramirez, Ignacio
Puente, Javier
机构：
[1] Complejo Hosp Univ Insular Materno Infantil, Med Oncol Dept, Las Palmas Gran Canaria, Spain
[2] Univ Hosp La Princesa, Fdn Inst Roche Med Personalizada Precis, Med Oncol Dept, Catedra UAM, Madrid, Spain
[3] Hosp Univ Ramon & Cajal, Med Oncol Dept, Madrid, Spain
[4] MD Anderson Canc Ctr Madrid, Dept Med Oncol, Madrid, Spain
[5] Ctr Integral Oncol Clara Campal CIOCC, Med Oncol Dept, Madrid, Spain
[6] Hosp Univ St Joan de Reus, Inst Oncol Catalunya Sud IOCS, Med Oncol Dept, IISPV,URV, Tarragona, Spain
[7] Univ Hosp Lucus Augusti, Med Oncol Dept, Lugo, Spain
[8] Univ Hosp Dr Peset, Med Oncol Dept, Valencia, Spain
[9] Univ Hosp Severo Ochoa, Med Oncol Dept, Leganes, Spain
[10] Univ Hosp Badajoz, Med Oncol Dept, Badajoz, Spain
[11] Complexo Hosp Univ Ourense, Med Oncol Dept, Orense, Spain
[12] Univ Hosp Arnau Vilanova, Fdn Fomento Invest Sanitaria & Biomed Comun Valenc, Med Oncol Dept, Valencia, Spain
[13] Univ Hosp Son Llatzer, Med Oncol Dept, Palma De Mallorca, Spain
[14] Univ Hosp Lluis Alcaniz Xativa, Med Oncol Dept, Valencia, Spain
[15] Hosp Clin Barcelona, Med Oncol Dept, Translat Genom & Targeted Therapeut Solid Tumors G, Barcelona, Spain
[16] Hosp Santa Creu & Sant Pau, Med Oncol Dept, Barcelona, Spain
[17] Roche Farma SA, Med Dept, Madrid, Spain
[18] Hosp Clin San Carlos, Inst Invest Sanitaria Hosp Clin San Carlos IdISSC, Med Oncol Dept, Madrid, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 5_SUPPL期
关键词：
D O I：
10.1200/JCO.2025.43.5_suppl.720
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma.
    Tural, Deniz
    Olmez, Omer Fatih
    Sumbul, Ahmet Taner
    Artac, Mehmet
    Ozhan, Nail
    Akar, Emre
    Cakar, Burcu
    Kostek, Osman
    Ekenel, Meltem
    Coskun, Hasan Senol
    Selcukbiricik, Fatih
    Keskin, Ozge
    Turkoz, Fatma Paksoy
    Oruc, Kerem
    Bayram, Selami
    Yilmaz, Ugur
    Bilgetekin, Irem
    Yildiz, Birol
    Sendur, Mehmet Ali Nahit
    Erman, Mustafa
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [32] Cost-effectiveness analysis of contemporary first-line (1L) agents in locally advanced/metastatic urothelial carcinoma (la/mUC)
    Naqvi, Syed Arsalan Ahmed
    Faisal, Kunwer Sufyan
    Raina, Ammad
    Khakwani, Kaneez Zahra Rubab
    Bin Riaz, Zaryab
    Shah, Vishal S.
    Cobran, Ewan Kemar
    Singh, Parminder
    Hussain, Syed A.
    Bryce, Alan Haruo
    Bin Riaz, Irbaz
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [33] First-line avelumab for patients with PD-L1-positive metastatic or locally advanced urothelial cancer who are unfit for cisplatin
    Iacovelli, R.
    Ciccarese, C.
    Brunelli, M.
    Battelli, N.
    Buttigliero, C.
    Caserta, C.
    Buti, S.
    Santini, D.
    Carella, C.
    Galli, L.
    Verri, E.
    Ermacora, P.
    Merler, S.
    Masini, C.
    De Vivo, R.
    Milesi, L.
    Spina, F.
    Rizzo, M.
    Sperduti, I.
    Fornarini, G.
    Tortora, G.
    ANNALS OF ONCOLOGY, 2022, 33 (11) : 1179 - 1185
  • [34] Major advancements in first-line treatments for advanced urothelial cancer
    Atlas, Steven J.
    CANCER, 2024, 130 (03) : 333 - 334
  • [35] IMvigor210: updated analyses of first-line (1L) atezolizumab (atezo) in cisplatin (cis)-ineligible locally advanced/metastatic urothelial carcinoma (mUC)
    Bellmunt, J.
    Balar, A.
    Galsky, M. D.
    Loriot, Y.
    Theodore, C.
    Grande Pulido, E.
    Castellano, D.
    Retz, M.
    Niegisch, G.
    Bracarda, S.
    Necchi, A.
    Vaishampayan, U.
    Sridhar, S.
    Eigl, B. J.
    Hussain, S.
    van der Heijden, M.
    Danner, B.
    Mariathasan, S.
    Legrand, F.
    Rosenberg, J. E.
    ANNALS OF ONCOLOGY, 2016, 27
  • [36] Effectiveness and Safety of Cetuximab in First-Line Therapy of Metastatic Colorectal Cancer According to Frailty in the EREBUS Study
    Gouverneur, Amandine
    Coutureau, Juliette
    Rouyer, Magali
    Smith, Denis
    Francois, Eric
    Monnereau, Alain
    Balestra, Aurelie
    Jove, Jeremy
    Lassalle, Regis
    Moore, Nicholas
    Fourrier-Reglat, Annie
    Noize, Pernelle
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 520 - 521
  • [37] Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
    Socinski, M. A.
    Jotte, R. M.
    Cappuzzo, F.
    Orlandi, F.
    Stroyakovskiy, D.
    Nogami, N.
    Rodriguez-Abreu, D.
    Moro-Sibilot, D.
    Thomas, C. A.
    Barlesi, F.
    Finley, G.
    Kelsch, C.
    Lee, A.
    Coleman, S.
    Deng, Y.
    Shen, Y.
    Kowanetz, M.
    Lopez-Chavez, A.
    Sandler, A.
    Reck, M.
    Ahualli, A.
    Jarchum, G.
    Kaen, D. L.
    Kahl, S.
    Kotliar, M.
    Kowalyszyn, R. D.
    Lerzo, G.
    Magri, I
    Martin, C.
    Pastor, A.
    Picon, P.
    Streich, G.
    Varela, M.
    Blinman, P.
    Boyer, M.
    Crombie, C.
    Gauden, S.
    Gill, S.
    Hughes, B.
    John, T.
    Joshi, A.
    Kosmider, S.
    Lewis, C.
    Millward, M.
    Nordman, I
    Nott, L.
    O'Byrne, K.
    Parnis, F.
    Potasz, N.
    Richardson, G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (24): : 2288 - 2301
  • [38] First-line Immunotherapy in Metastatic Urothelial Carcinoma
    Ghatalia, Pooja
    Zibelman, Matthew
    Geynisman, Daniel M.
    Plimack, Elizabeth R.
    EUROPEAN UROLOGY FOCUS, 2020, 6 (01): : 45 - 47
  • [39] FOLFOX-6 combination as the first-line treatment of locally advanced and/or metastatic pancreatic cancer
    Ghosn, Marwan
    Farhat, Fadi
    Kattan, Joseph
    Younes, Fariha
    Moukadem, Walid
    Nasr, Fadi
    Chahine, Georges
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2007, 30 (01): : 15 - 20
  • [40] Gemcitabine Plus Irinotecan as First-Line Weekly Therapy in Locally Advanced and/or Metastatic Pancreatic Cancer
    Neri, B.
    Cipriani, G.
    Grifoni, R.
    Molinara, E.
    Pantaleo, P.
    Rangan, S.
    Vannini, A.
    Tonelli, P.
    Valeri, A.
    Pantalone, D.
    Taddei, A.
    Bechi, P.
    ONCOLOGY RESEARCH, 2009, 17 (11-12) : 559 - 564
12345